Similar articles

• Evidence of genetic diversity underlying Rh D-, weak D (Du), and partial D phenotypes as determined by multiplex polymerase chain reaction analysis of the RHD gene.

  Avent ND, Martin PG, Armstrong-Fisher SS, Liu W, Finning KM, Maddocks D, Urbaniak SJ. Avent ND, et al. Blood. 1997 Apr 1;89(7):2568-77. Blood. 1997. PMID: 9116304
• It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.

  Sandler SG, Flegel WA, Westhoff CM, Denomme GA, Delaney M, Keller MA, Johnson ST, Katz L, Queenan JT, Vassallo RR, Simon CD; College of American Pathologists Transfusion Medicine Resource Committee Work Group. Sandler SG, et al. Transfusion. 2015 Mar;55(3):680-9. doi: 10.1111/trf.12941. Epub 2014 Dec 1. Transfusion. 2015. PMID: 25438646 Free PMC article. No abstract available.
• The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in africans with the Rh D-negative blood group phenotype.

  Singleton BK, Green CA, Avent ND, Martin PG, Smart E, Daka A, Narter-Olaga EG, Hawthorne LM, Daniels G. Singleton BK, et al. Blood. 2000 Jan 1;95(1):12-8. Blood. 2000. PMID: 10607679
• Review: the Rh blood group D antigen... dominant, diverse, and difficult.

  Westhoff CM. Westhoff CM. Immunohematology. 2005;21(4):155-63. Immunohematology. 2005. PMID: 16472017 Review. No abstract available.
• Molecular biology of the Rh system: clinical considerations for transfusion in sickle cell disease.

  Chou ST, Westhoff CM. Chou ST, et al. Hematology Am Soc Hematol Educ Program. 2009:178-84. doi: 10.1182/asheducation-2009.1.178. Hematology Am Soc Hematol Educ Program. 2009. PMID: 20008197 Review.